Market Outlook

By 2035, the U.S. Endoscopy Devices Market is projected to reach approximately USD 41.77 billion, expanding at a CAGR of 8.22% during the forecast period from 2026 to 2035. The market is estimated at USD 18.95 billion in 2025, following an increase from approximately USD 13.70 billion in 2021, USD 14.76 billion in 2022, USD 16.02 billion in 2023, and USD 17.47 billion in 2024. All values in this report are expressed in USD billions.

The U.S. endoscopy devices industry is evolving from a predominantly visualization-focused market into a clinically integrated ecosystem encompassing reusable and single-use endoscopes, endoscopic imaging platforms, endotherapy instruments, robotic navigation, artificial intelligence, advanced tissue characterization, reprocessing systems, electrosurgical devices, insufflation equipment, fluid-management technologies, and recurring service contracts. Market growth is being supported by high gastrointestinal procedure volumes, rising colorectal cancer screening requirements, increasing minimally invasive surgery utilization, expanding pulmonary nodule evaluation, outpatient migration, and replacement demand for high-definition visualization systems.

More than 20 million gastrointestinal endoscopic procedures are estimated to be performed annually in the United States. Colonoscopy, upper gastrointestinal endoscopy, endoscopic retrograde cholangiopancreatography, endoscopic ultrasound, bronchoscopy, cystoscopy, arthroscopy, laparoscopy, hysteroscopy, and ear-nose-throat endoscopy collectively create a substantial installed base and recurring consumables opportunity. The market also benefits from the fact that many endoscopic procedures combine capital equipment with procedure-specific accessories, creating revenue across multiple stages of the clinical workflow.

Colorectal cancer remains an especially important demand driver. Approximately 148,000 new colorectal cancer cases were reported in the United States in 2022, while close to 54,000 colorectal cancer deaths occurred in 2023. Screening guidelines recommending colorectal cancer screening beginning at age 45 have expanded the addressable population, but screening participation remains below national targets. An estimated 28 million adults between 45 and 75 years of age have never undergone recommended screening, indicating substantial latent demand for colonoscopy, polypectomy, biopsy, hemostasis, and surveillance technologies.

The market is also closely connected to U.S. hospital and ambulatory infrastructure. The country has more than 6,000 hospitals, over 913,000 staffed hospital beds, approximately 34 million annual hospital admissions, and more than 6,000 Medicare-certified ambulatory surgery centers. Endoscopy is one of the most established procedure categories in ambulatory settings because many cases can be completed within a predictable episode of care, require limited postoperative recovery, and are supported by established reimbursement pathways.

The market-sizing framework used for this report includes flexible and rigid endoscopes, capsule endoscopy systems, endoscopic imaging and visualization platforms, endotherapy instruments, endoscopic accessories, insufflation and fluid-management equipment, electrosurgical technologies, endoscope reprocessing and storage systems, dedicated software, maintenance contracts, and endoluminal robotic systems. It excludes physician and facility procedure fees, pharmaceuticals, general-purpose operating-room equipment, and the full value of multispecialty robotic surgery platforms unless the revenue is directly attributable to endoscopic access or endoluminal intervention.

Historically, market expansion between 2021 and 2024 was supported by the recovery of deferred screening procedures, renewed hospital capital budgets, increased ambulatory surgery utilization, replacement of aging video processors, rising single-use bronchoscope and cystoscope adoption, and accelerated demand for endoscopic hemostasis and tissue-acquisition devices. Growth in 2025 was strengthened by investments in 4K visualization, artificial intelligence-assisted lesion detection, endoscopic ultrasound, robotic bronchoscopy, sterile single-use scopes, and integrated endoscopy-room infrastructure.

From 2026 through 2035, the market will increasingly be shaped by technologies that improve lesion detection, enable endoscopic therapy in place of surgery, reduce infection-control burden, support outpatient economics, and generate measurable clinical workflow improvements. Manufacturers able to combine capital equipment, consumables, software, service, clinical education, and reimbursement support will be positioned more favorably than suppliers competing primarily on stand-alone device specifications.

 

Introduction

According to the U.S. Endoscopy Devices Market Report, endoscopy is embedded across gastrointestinal medicine, general surgery, pulmonary medicine, urology, gynecology, orthopedics, otolaryngology, and interventional oncology. This diversified clinical footprint makes the market more resilient than device categories dependent on a single procedure or specialty.

Gastrointestinal endoscopy remains the largest contributor because of the frequency of colonoscopy and upper gastrointestinal procedures and the growing therapeutic role of endoscopic ultrasound, endoscopic mucosal resection, endoscopic submucosal dissection, endoscopic suturing, biliary drainage, pancreatic intervention, and bariatric endoscopy. Pulmonology is emerging as a premium technology market because peripheral lung lesions frequently require advanced navigation, radial ultrasound, cone-beam imaging, robotic bronchoscopy, and specialized biopsy tools. Urology, arthroscopy, laparoscopy, hysteroscopy, and ENT procedures provide additional recurring demand for rigid and flexible scopes, cameras, light sources, access devices, pumps, fluid-management equipment, and sterile consumables.

The U.S. market contains both mature and high-growth device categories. Conventional reusable flexible endoscopes, camera heads, light sources, rigid telescopes, biopsy forceps, snares, trocars, and electrosurgical accessories provide a stable revenue base. Faster-growing categories include disposable bronchoscopes, disposable cystoscopes, single-use duodenoscopes, artificial intelligence-assisted colonoscopy, advanced endoscopic suturing, lumen-apposing metal stents, robotic bronchoscopy, capsule endoscopy, disposable valves and tubing, and automated reprocessing technologies.

Endoscopy procurement decisions are increasingly made through multidisciplinary value-analysis committees. Physicians assess image quality, maneuverability, therapeutic capability, ergonomics, and procedural confidence. Nursing and sterile-processing teams evaluate cleaning complexity, turnover time, occupational exposure, drying, storage, traceability, and compliance requirements. Finance executives examine capital cost, service expense, repair frequency, procedure reimbursement, disposable utilization, room throughput, and total cost per case.

This purchasing environment favors companies that can quantify economic value beyond the device price. A visualization platform that reduces repeated examinations, a hemostasis device that avoids surgery, an artificial intelligence tool that improves adenoma detection, or a single-use scope that eliminates emergency reprocessing can justify premium pricing when the clinical and operational consequences are measurable.

Hospital consolidation is also changing market access. Large integrated delivery networks increasingly standardize endoscopy platforms across hospitals, ambulatory centers, and physician practices. Enterprise agreements may combine imaging towers, flexible scopes, surgical cameras, service contracts, repair programs, reprocessing equipment, and procedure-based consumables. Standardization can improve training and inventory efficiency, but it raises the commercial importance of system interoperability and long-term account relationships.

The next decade of the U.S. endoscopy devices market will be defined by a shift from basic visualization toward image-guided diagnosis and incisionless therapy. Endoscopy is becoming a platform through which clinicians detect disease, characterize tissue, obtain pathology samples, control bleeding, remove lesions, drain fluid collections, place stents, revise anatomy, and monitor treatment response. The commercial value of the market will therefore expand faster than procedure volume alone.

 

Key Market Drivers: What’s Fueling the U.S. Endoscopy Devices Market Boom?

The first major driver is the scale of gastrointestinal disease and colorectal cancer screening demand. Millions of U.S. adults require colonoscopy for initial screening, surveillance after polyp removal, family-history evaluation, inflammatory bowel disease monitoring, gastrointestinal bleeding, anemia, and diagnostic follow-up after non-invasive screening tests. Lowering the recommended starting age for average-risk colorectal cancer screening from 50 to 45 expanded the eligible population and created a sustained backlog of adults requiring screening.

Screening gaps represent an important commercial opportunity. Only about six in ten adults between 45 and 75 years of age are estimated to be up to date with colorectal cancer screening when the younger eligible population is included. Increasing participation toward national targets would create additional demand for colonoscopes, artificial intelligence-assisted detection, snares, forceps, clips, irrigation devices, electrosurgical units, pathology collection systems, and reprocessing capacity.

A second driver is the transition from open surgery to minimally invasive and endoluminal procedures. Endoscopy increasingly allows clinicians to treat lesions that historically required surgical intervention. Advanced polypectomy, endoscopic mucosal resection, endoscopic submucosal dissection, endoscopic full-thickness resection, endoscopic suturing, peroral endoscopic myotomy, transoral outlet reduction, endoscopic sleeve gastroplasty, and endoscopic drainage can reduce abdominal incisions, shorten recovery, and expand treatment options for medically complex patients.

The economic implications are significant. Hospitals can improve bed availability when appropriate cases shift to outpatient or short-stay pathways. Payers may benefit when effective endoscopic intervention replaces more expensive surgery. Patients may experience less postoperative pain, shorter recovery, and faster return to normal activity. These advantages are increasing demand for high-performance therapeutic endoscopes and specialized accessories.

A third driver is the growth of ambulatory endoscopy. Colonoscopy, upper gastrointestinal endoscopy, selected endoscopic ultrasound procedures, cystoscopy, arthroscopy, hysteroscopy, and other low-acuity procedures are frequently performed in ambulatory surgery centers and specialty facilities. The U.S. has more than 6,000 Medicare-certified ASCs, and gastroenterology is one of the most established ASC specialties.

Ambulatory buyers generally prioritize compact platforms, predictable service costs, quick room turnover, dependable scope availability, simple staff training, and efficient inventory management. Unlike tertiary hospitals, many independent centers do not maintain large fleets of backup scopes or extensive biomedical engineering resources. This increases the value of high reliability, modular equipment, rapid repair support, and selective single-use deployment.

A fourth driver is the need to modernize the installed base. Many U.S. health systems are replacing older standard-definition and early high-definition systems with 4K imaging, improved light-source technology, enhanced contrast modes, digital documentation, integrated operating-room connectivity, and software-enabled quality measurement. Replacement decisions are often accelerated when legacy systems experience rising repair costs or cannot support newer therapeutic scopes and artificial intelligence modules.

Capital replacement is rarely limited to a single device. A platform conversion may involve processors, light sources, monitors, insufflators, pumps, camera heads, scopes, carts, software licenses, storage, service agreements, and staff training. Consequently, an imaging-platform win can create a multiyear stream of consumables, repairs, upgrades, and accessories.

A fifth driver is the increasing use of artificial intelligence. Computer-aided detection systems are being incorporated into colonoscopy workflows to identify suspected polyps and reduce the risk that subtle lesions are overlooked. Artificial intelligence is also being evaluated for lesion characterization, Barrett’s esophagus assessment, inflammatory bowel disease scoring, capsule endoscopy interpretation, endoscopic ultrasound guidance, and bronchoscopy navigation.

The commercial advantage of artificial intelligence will depend on workflow integration rather than algorithm performance alone. Systems must operate without creating disruptive latency, excessive false-positive alerts, additional documentation burden, or complex data-security requirements. Products that integrate with existing processors and reporting systems are more likely to achieve enterprise adoption.

A sixth driver is infection prevention and reprocessing complexity. Reusable endoscopes require meticulous bedside pre-cleaning, leak testing, manual cleaning, high-level disinfection or sterilization where indicated, drying, transport, storage, and documentation. Failure at any stage can increase contamination risk and expose health systems to patient-safety, regulatory, and reputational consequences.

Duodenoscopes and other complex reusable designs have received particular attention because internal channels and elevator mechanisms can be difficult to clean. This has stimulated investment in disposable components, redesigned reusable scopes, single-use scopes, automated endoscope reprocessors, drying cabinets, surveillance testing, traceability software, and standardized reprocessing workflows.

A seventh driver is pulmonary nodule detection and lung-cancer diagnosis. Increased use of chest imaging identifies small peripheral lung nodules that can be difficult to reach with conventional bronchoscopy. Robotic and navigational bronchoscopy systems are designed to improve access to peripheral lesions and support tissue acquisition. As lung-cancer screening expands, demand is expected to rise for advanced bronchoscopes, navigation software, biopsy needles, forceps, imaging integration, and pathology-enabling accessories.

An eighth driver is the aging population. Older adults have a higher incidence of colorectal neoplasia, biliary disease, gastrointestinal bleeding, dysphagia, pancreatic disorders, urinary disease, and pulmonary nodules. By 2030, all members of the baby-boom generation will be older than 65, expanding Medicare-age demand for diagnostic and therapeutic endoscopy. The aging population also strengthens the case for lower-trauma procedures that can be performed without major surgery.

A ninth driver is the growth of obesity and metabolic disease. Approximately two in five U.S. adults live with obesity, supporting demand for gastrointestinal evaluation, reflux assessment, bariatric surgery, and emerging endoscopic weight-management procedures. Endoscopic sleeve gastroplasty and related therapies are commercially relevant because they position gastroenterologists within the obesity-treatment pathway and may provide an option between medication and surgery for selected patients.

A tenth driver is manufacturer investment in clinical education. Advanced endoscopy adoption depends on physician training, proctoring, case support, procedural standardization, and competency development. Companies that build training centers, support fellowship programs, generate registry data, and maintain experienced field clinical teams can accelerate adoption while creating durable physician relationships.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. endoscopy devices market is concentrated around image quality, intelligent detection, therapeutic capability, disposable technology, navigation, workflow integration, and infection control. The leading manufacturers are increasingly building endoscopy ecosystems rather than isolated products.

High-definition, 4K, and enhanced imaging systems remain central to competition. Improvements in sensor resolution, depth of field, illumination, contrast, color reproduction, and digital processing can help clinicians identify flat lesions, vascular abnormalities, subtle mucosal changes, and tissue boundaries. Advanced imaging modes are increasingly incorporated into routine workflows rather than reserved for academic centers.

Artificial intelligence is becoming the analytical layer of the imaging platform. In colonoscopy, computer-aided detection highlights suspected lesions in real time. Future systems are expected to provide more integrated support across procedure documentation, withdrawal-time monitoring, bowel-preparation scoring, lesion characterization, quality benchmarking, and follow-up recommendations.

The commercial model is likely to move toward software licensing, subscription arrangements, per-procedure fees, or enterprise contracts. This creates recurring revenue, but health systems will require evidence that the software improves measurable outcomes rather than simply adding visual alerts.

Single-use endoscopy represents another major innovation cycle. Disposable bronchoscopes have gained adoption in intensive care, emergency care, isolation environments, operating rooms, and situations where immediate scope availability is important. Single-use cystoscopes and ureteroscopes are increasingly used where scope damage, repair expense, contamination concern, or low procedural volume makes reusable economics less attractive.

The gastrointestinal market remains more resistant to complete conversion because reusable scopes generally provide high image quality and favorable economics at high procedure volumes. However, selective adoption is likely in emergency procedures, immunocompromised patients, difficult-to-reprocess designs, remote sites, and facilities without sufficient reprocessing infrastructure.

Therapeutic endoscopy is also moving into increasingly complex disease management. Lumen-apposing metal stents have changed drainage pathways for pancreatic fluid collections and selected biliary interventions. Endoscopic suturing and tissue-closure technologies are supporting bariatric procedures, perforation management, fistula closure, and defect repair. Improved clips, hemostatic powders, thermal devices, and Doppler-guided technologies are strengthening the endoscopic management of gastrointestinal bleeding.

Robotic and computer-assisted endoscopy is developing most rapidly in pulmonology and advanced therapeutic procedures. Shape-sensing and robotic bronchoscopic platforms can support navigation to peripheral lung lesions, while new endoluminal robotic systems are being developed to provide greater instrument stability and bimanual control. These platforms could expand the complexity of procedures that can be completed through natural orifices.

Capsule endoscopy continues to evolve through improved battery life, wider viewing angles, higher frame rates, localization capabilities, and artificial intelligence-assisted reading. Its strongest current use remains small-bowel evaluation, particularly for obscure bleeding and suspected inflammatory disease. Longer-term opportunities include expanded colon imaging, remote interpretation, and integration with digital diagnostic pathways.

Reprocessing innovation is focused on automated cleaning support, channel surveillance, drying, storage, traceability, and redesigned scopes with disposable components. Procurement teams increasingly evaluate the full reprocessing lifecycle, including labor, chemicals, water, drying time, storage capacity, repair exposure, and staff safety.

Endoscopy-room integration is another important area. Modern systems can connect video, patient data, electronic records, procedure reports, operating-room controls, and remote collaboration. Integrated rooms support faster setup and more consistent documentation, although interoperability and cybersecurity have become critical purchasing considerations.

Manufacturers are also improving device ergonomics. Lighter handles, better torque response, reduced insertion resistance, improved articulation, and more intuitive accessory control can reduce operator fatigue. Ergonomic differentiation is commercially meaningful because gastroenterologists and surgeons face occupational risks from repetitive procedures and awkward positioning.

Clinical evidence is becoming essential to premium pricing. U.S. buyers increasingly request comparative trials, health-economic models, real-world performance data, quality metrics, and evidence that new devices reduce repeat procedures, adverse events, repair costs, procedure time, or hospital utilization. Innovation without economic documentation is less likely to achieve broad system-level adoption.

 

Segmentation Insights

The U.S. Endoscopy Devices Market is segmented on the basis of product category, application, end user, technology type, and region.

By Product Category

Endoscopes

Endoscopes represent the largest foundational product category and include flexible gastrointestinal endoscopes, bronchoscopes, cystoscopes, ureteroscopes, rigid laparoscopes, arthroscopes, hysteroscopes, rhinoscopes, capsule endoscopes, and specialty endoscopes. The segment is estimated to account for approximately USD 5.60 billion in 2025.

Reusable flexible endoscopes dominate high-volume gastrointestinal facilities because their economics improve when the device is used frequently and supported by efficient reprocessing. Single-use models are growing faster in bronchoscopy, urology, ENT, and selected gastrointestinal applications. Demand is influenced by procedure volume, image quality, durability, repair frequency, channel size, therapeutic compatibility, and reprocessing requirements.

Visualization and Imaging Systems

Visualization systems include video processors, camera control units, camera heads, light sources, monitors, image-management systems, recording systems, carts, integrated operating-room controls, and dedicated software. This segment is estimated at approximately USD 4.35 billion in 2025.

Replacement cycles typically range from five to eight years but can be shorter when health systems pursue enterprise standardization or when older platforms cannot support artificial intelligence and advanced imaging. Premium growth is concentrated in 4K, fluorescence imaging, enhanced contrast, three-dimensional visualization, digital integration, and software-enabled quality analysis.

Endotherapy Devices and Procedure Accessories

Endotherapy devices and accessories are estimated to generate approximately USD 5.20 billion in 2025, making the category one of the largest recurring-revenue pools. The segment includes biopsy forceps, snares, guidewires, dilation balloons, retrieval devices, clips, injectors, needles, cytology brushes, stents, suturing systems, tissue-closure devices, hemostatic products, sphincterotomes, baskets, valves, caps, tubing, and irrigation accessories.

Growth is driven by procedure frequency and expanding therapeutic complexity. Unlike capital systems, most products are consumed during each procedure, creating predictable recurring demand. The strongest value growth is expected in endoscopic ultrasound accessories, biliary and pancreatic intervention, advanced tissue resection, hemostasis, suturing, and specialty stents.

Insufflation, Fluid Management and Electrosurgical Systems

This category is valued at approximately USD 2.00 billion in 2025 and includes insufflators, smoke evacuation, irrigation pumps, fluid-management systems, electrosurgical generators, plasma coagulation devices, energy instruments, suction systems, and associated tubing.

Growth is supported by the need for stable visualization, controlled insufflation, efficient irrigation, and precise tissue treatment. Hospitals increasingly prefer systems that integrate with the broader visualization platform, provide safety monitoring, and simplify room setup. Disposable tubing and procedure packs create a recurring revenue component.

Reprocessing, Storage, Service and Infection-Prevention Products

Reprocessing and related services account for an estimated USD 1.80 billion in 2025. Products include automated endoscope reprocessors, drying cabinets, transport containers, leak testers, detergents, disinfectants, tracking software, storage systems, channel-testing technologies, and maintenance contracts.

This category is becoming strategically important because the true cost of reusable endoscopy extends beyond scope acquisition. Labor, water, chemicals, repair, drying, storage, compliance, and documentation materially influence total cost per procedure. Health systems are investing in automated, traceable, and standardized reprocessing environments to reduce variability and regulatory risk.

 

By Application

Gastrointestinal Endoscopy

Gastrointestinal endoscopy is the largest application segment, representing an estimated USD 8.20 billion in 2025. It includes colonoscopy, upper gastrointestinal endoscopy, endoscopic retrograde cholangiopancreatography, endoscopic ultrasound, capsule endoscopy, enteroscopy, therapeutic resection, hemostasis, stenting, and bariatric endoscopy.

Demand is supported by colorectal cancer screening, gastrointestinal bleeding, reflux disease, dysphagia, inflammatory bowel disease, pancreatic disorders, biliary disease, anemia, and polyp surveillance. Growth is moving from routine visualization toward therapeutic procedures that require advanced scopes, accessory channels, energy systems, suturing, stents, and imaging guidance.

Laparoscopy and General Surgery

Laparoscopy and minimally invasive general surgery account for approximately USD 4.10 billion in 2025. Applications include cholecystectomy, hernia repair, bariatric surgery, colorectal surgery, appendectomy, anti-reflux surgery, thoracoscopy, and other minimally invasive procedures.

The segment benefits from continuous replacement of surgical camera systems, growing demand for fluorescence imaging, and increased adoption of integrated operating rooms. Competition is closely connected to surgeon preference, equipment standardization, service quality, and compatibility with energy and insufflation systems.

Pulmonology and Bronchoscopy

Pulmonology represents an estimated USD 2.35 billion market in 2025 and is expected to record one of the highest growth rates through 2035. The segment includes reusable and single-use bronchoscopes, endobronchial ultrasound, navigation systems, robotic bronchoscopy, biopsy tools, cytology instruments, needles, forceps, and airway-management accessories.

Growth is supported by lung-cancer screening, peripheral nodule detection, intensive-care bronchoscopy, infection-control requirements, and demand for more accurate tissue acquisition. Robotic navigation is raising the capital intensity of the segment while creating recurring revenue through catheters and biopsy accessories.

Urology

Urological endoscopy is estimated at USD 2.25 billion in 2025. The segment includes cystoscopy, ureteroscopy, nephroscopy, resectoscopy, stone-management procedures, bladder-tumor evaluation, and other minimally invasive urological interventions.

Single-use cystoscopes and ureteroscopes are gaining adoption because reusable devices can be vulnerable to damage and repair expense. The commercial decision depends on case volume, repair rates, reprocessing availability, image requirements, physician preference, and the ability to guarantee scope availability for urgent procedures.

ENT, Gynecology, Arthroscopy and Other Applications

Combined ENT, gynecology, arthroscopy and other applications account for approximately USD 2.05 billion in 2025. These specialties use rigid and flexible scopes, surgical cameras, pumps, fluid-management systems, shavers, access devices, hysteroscopes, rhinoscopes, laryngoscopes, and specialty instruments.

The segment benefits from outpatient migration and the need for compact, specialty-specific equipment. Arthroscopy remains a significant contributor to surgical visualization demand, while office hysteroscopy and ENT endoscopy create opportunities for smaller systems and disposable scopes.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and health systems are the largest end-user segment, accounting for an estimated USD 9.10 billion in 2025. They perform the majority of complex gastrointestinal, pulmonary, surgical, emergency, and high-acuity endoscopic procedures.

Large systems purchase through enterprise contracts and often evaluate platform standardization across multiple facilities. Their requirements include clinical breadth, cybersecurity, electronic-record integration, repair support, loaner availability, training, and predictable service performance.

Ambulatory Surgery Centers

Ambulatory surgery centers account for approximately USD 5.15 billion in 2025 and are expected to gain market share through 2035. Gastroenterology-driven ASCs generate high colonoscopy and upper-endoscopy volumes, while multispecialty centers support urology, orthopedics, gynecology, and general surgery.

ASC economics favor reliable equipment, rapid turnover, efficient room utilization, and disciplined consumables management. Facilities may avoid technologies that create excessive capital or staffing complexity unless the procedure volume can support a clear return on investment.

Specialty Endoscopy Centers and Physician-Owned Clinics

Specialty centers and physician-owned facilities represent approximately USD 2.70 billion in 2025. These organizations can be highly procedure-focused and commercially sophisticated. Many have strong physician influence over purchasing and closely monitor cost per case, reimbursement, repair expense, and schedule utilization.

Vendors that provide customized financing, responsive local service, scope-leasing programs, and consumables agreements can compete effectively in this segment.

Academic Medical Centers and Research Institutions

Academic and tertiary centers account for approximately USD 1.15 billion in 2025. Although smaller by total value, they are strategically important because they perform complex procedures, participate in clinical trials, train specialists, and influence national adoption.

New technologies such as robotic bronchoscopy, endoscopic suturing, advanced resection, artificial intelligence, and endoluminal robotics commonly penetrate these institutions before expanding into community care.

Office-Based Facilities and Other Care Settings

Office-based facilities, diagnostic practices, emergency departments, intensive-care units, and other settings represent approximately USD 0.85 billion in 2025. Demand includes office cystoscopy, ENT endoscopy, portable bronchoscopy, capsule endoscopy, and compact visualization systems.

Single-use scopes are particularly relevant where case volumes are insufficient to support reprocessing infrastructure or where immediate device availability is clinically important.

 

By Technology Type

Reusable Endoscopy Platforms

Reusable systems remain the largest technology category because of their installed base, premium imaging performance, and favorable economics in high-volume settings. They dominate gastrointestinal endoscopy, advanced laparoscopy, arthroscopy, and complex therapeutic procedures.

Growth will be driven primarily by replacement cycles, platform upgrades, service contracts, and compatibility with artificial intelligence rather than by rapid unit-volume expansion.

Single-Use Endoscopy

Single-use endoscopy is expected to be the fastest-growing technology segment through 2035. Adoption is strongest in bronchoscopy and urology, where sterile availability, emergency access, reduced repair exposure, and elimination of reprocessing can provide economic value.

GI conversion will be more selective because high-volume facilities can achieve lower per-case costs with reusable systems. The strongest opportunities are likely to involve difficult-to-clean devices, emergency procedures, low-volume sites, and high-risk patient populations.

High-Definition, 4K and Three-Dimensional Visualization

Advanced visualization technologies are becoming standard in surgical and premium diagnostic environments. Adoption is supported by improved image detail, larger operating-room displays, fluorescence capability, and the need to identify subtle anatomical boundaries.

Health systems increasingly purchase these technologies as integrated platforms rather than stand-alone cameras. Replacement decisions are closely linked to service support, standardization, and compatibility with existing scopes and instruments.

Artificial Intelligence and Advanced Imaging

Artificial intelligence, virtual chromoendoscopy, fluorescence imaging, spectral enhancement, and computer-assisted analysis represent a high-growth technology layer. These systems support lesion detection, tissue characterization, procedural quality, and clinical documentation.

Commercial success will depend on evidence, reimbursement, interoperability, and physician trust. Artificial intelligence is likely to become increasingly embedded within processors rather than sold as an entirely separate workflow.

Robotic, Navigational and Capsule Endoscopy

Robotic bronchoscopy, electromagnetic or shape-sensing navigation, capsule endoscopy, and emerging endoluminal robotic platforms are projected to grow at a double-digit rate from a smaller base. These technologies expand anatomical reach and may improve diagnostic or therapeutic precision.

Adoption will initially remain concentrated in academic centers and high-volume referral facilities because of capital requirements, training needs, and the importance of supporting imaging infrastructure.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. Endoscopy Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand differs according to population size, age distribution, colorectal screening participation, obesity prevalence, hospital density, ASC concentration, specialist availability, urban growth, payer mix, and access to advanced tertiary care.

The South is the largest market, the West is expected to record the fastest growth, the Northeast remains the most innovation-intensive region, and the Midwest provides a stable base of mature hospital and ambulatory demand.

South

The South accounted for an estimated USD 6.44 billion in 2025 and is projected to reach approximately USD 14.16 billion by 2035, representing a CAGR of about 8.20%. The region’s leadership is supported by its large population, rapidly expanding metropolitan areas, high gastrointestinal disease burden, elevated obesity prevalence, growing Medicare population, and expanding ambulatory infrastructure.

Texas is the largest Southern state market. Houston, Dallas-Fort Worth, Austin, and San Antonio support major academic hospitals, integrated delivery networks, physician-owned endoscopy centers, and high-volume surgical programs. Demand is broad across colonoscopy, bariatric endoscopy, bronchoscopy, urology, laparoscopy, and advanced gastrointestinal intervention.

Florida is another major demand center because of its large older-adult population and extensive network of hospitals, gastroenterology groups, cancer centers, and ASCs. The state has strong demand for colorectal cancer screening, biliary intervention, gastrointestinal bleeding management, cystoscopy, and pulmonary nodule evaluation.

North Carolina benefits from research-oriented medical centers, biotechnology investment, population growth, and strong regional referral networks. Charlotte, Raleigh-Durham, Winston-Salem, and the Research Triangle support adoption of advanced imaging, artificial intelligence, therapeutic endoscopy, and robotic bronchoscopy.

Georgia is driven by Atlanta’s large health systems, expanding suburban population, and significant ambulatory procedure capacity. Tennessee benefits from major provider organizations in Nashville, Memphis, Knoxville, and Chattanooga, while Virginia has advanced academic and integrated systems across Northern Virginia, Richmond, Charlottesville, and Hampton Roads.

Maryland is strengthened by its academic and federal healthcare ecosystem, while Delaware has a smaller but commercially attractive market supported by insured populations and proximity to major Northeastern referral networks. South Carolina continues to expand endoscopy capacity in Charleston, Columbia, Greenville, and rapidly growing coastal communities.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia have substantial digestive-disease and obesity burdens but uneven access to advanced endoscopy. Large referral centers in these states remain attractive for premium equipment, while community and rural facilities create opportunities for portable, single-use, and simplified systems.

Louisiana has important demand related to gastrointestinal disease, hepatobiliary care, and urban referral centers in New Orleans and Baton Rouge. Kentucky is supported by Louisville and Lexington, while Oklahoma’s primary commercial demand is concentrated in Oklahoma City and Tulsa. Arkansas and Mississippi remain more price-sensitive and require strong distributor coverage and service availability.

The South will remain the largest regional market through 2035. Growth will be supported by outpatient center construction, hospital-system expansion, colorectal screening demand, obesity-treatment pathways, single-use endoscopy, and increased access to advanced pulmonary and gastrointestinal procedures.

West

The West represented approximately USD 4.74 billion in 2025 and is expected to reach USD 11.36 billion by 2035, expanding at a CAGR of approximately 9.13%. It is projected to be the fastest-growing region because of technology adoption, population movement, medtech innovation, digital-health integration, and expansion of large health systems in high-growth states.

California is the largest Western state market and one of the most influential endoscopy markets nationally. The state combines a very large population with academic medical centers, cancer programs, integrated delivery networks, technology developers, and venture-backed device companies. California is especially important for artificial intelligence-assisted endoscopy, advanced resection, robotic bronchoscopy, endoscopic bariatric procedures, and clinical trials.

Washington has strong integrated provider systems and high adoption of connected operating-room technology, while Oregon has a consolidated health-system market that values clinical evidence, standardization, and total-cost analysis. Both states are relevant for artificial intelligence, digital documentation, single-use bronchoscopy, and enterprise platform contracts.

Arizona and Nevada are fast-growing endoscopy markets because of population growth and aging demographics. Phoenix, Tucson, Las Vegas, and Reno are expanding hospital and ASC capacity, creating demand for colonoscopy, urology, pulmonary diagnosis, and minimally invasive surgery.

Colorado has a sophisticated provider market centered on Denver and the Front Range. The state is attractive for advanced pulmonary navigation, surgical imaging, sports-medicine arthroscopy, and outpatient gastroenterology. Utah combines rapid population growth with large integrated systems and a strong technology-oriented procurement environment.

New Mexico has a smaller but clinically important market shaped by large geographic distances, rural access requirements, and the need for referral-based specialty care. Portable systems and single-use scopes can be valuable where reprocessing and repair logistics are challenging.

Idaho, Montana, and Wyoming are lower-volume states but are growing as regional health systems expand. These markets require dependable field service and equipment suitable for community hospitals. Tele-education, mobile clinical support, and simplified reprocessing workflows can improve commercial adoption.

Alaska and Hawaii face unique logistics and supply-chain constraints. Their isolated geography increases the importance of device reliability, inventory planning, repair turnaround, and emergency scope availability. Single-use devices can be attractive for selected applications where rapid access is more important than high-volume reusable economics.

The West’s growth will be driven by technology replacement, artificial intelligence, robotic bronchoscopy, fluorescence imaging, single-use adoption, and investment in advanced outpatient facilities.

Northeast

The Northeast accounted for approximately USD 4.55 billion in 2025 and is projected to reach USD 9.48 billion by 2035, representing a CAGR of approximately 7.62%. The region is mature but remains one of the highest-value markets on a per-procedure basis.

New York is the largest Northeastern market. New York City, Long Island, Westchester, Albany, Buffalo, and Rochester support extensive academic, community, and ambulatory infrastructure. The state has strong demand for complex gastrointestinal procedures, artificial intelligence, pulmonary navigation, advanced surgical visualization, and enterprise service agreements.

Pennsylvania has large health systems in Philadelphia, Pittsburgh, central Pennsylvania, and the Lehigh Valley. Its market is diversified across tertiary hospitals, community facilities, physician-owned endoscopy centers, and cancer programs.

Massachusetts is highly influential because of its academic hospitals, research institutions, medical-device innovation, and early adoption of advanced endoscopy. The state is an important launch environment for artificial intelligence, therapeutic endoscopy, robotic systems, and evidence generation.

New Jersey benefits from high population density, strong commercial insurance participation, proximity to New York and Philadelphia, and extensive ambulatory care. Connecticut has a concentrated health-system market with strong adoption of premium surgical and gastrointestinal technologies.

Rhode Island, New Hampshire, Maine, and Vermont are smaller state markets. Rhode Island is centered on Providence’s academic and hospital network. New Hampshire combines community hospitals with access to Boston-based referral care. Maine and Vermont require vendors to support geographically dispersed facilities, making reliability and service coverage especially important.

The Northeast’s slower population growth limits procedure expansion relative to the South and West, but the region will remain commercially important because of high-acuity cases, research activity, specialist concentration, and demand for premium technology.

Midwest

The Midwest represented approximately USD 3.22 billion in 2025 and is expected to reach USD 6.77 billion by 2035, expanding at a CAGR of approximately 7.71%. The region is characterized by mature hospital networks, established gastroenterology practices, significant chronic-disease burden, and strong regional referral systems.

Illinois is the largest Midwestern state market, led by Chicago’s academic hospitals, integrated systems, cancer centers, and large ambulatory base. The state supports broad demand for gastrointestinal, surgical, pulmonary, urological, and orthopedic endoscopy.

Ohio has major clinical hubs in Cleveland, Columbus, and Cincinnati and is important for advanced gastrointestinal care, pulmonary intervention, and hospital-system procurement. Michigan has strong demand centered on Detroit, Ann Arbor, Grand Rapids, and regional community systems.

Minnesota is strategically important because of its medical-technology heritage, academic care, and sophisticated hospital purchasing environment. Wisconsin has a strong integrated health-system structure and substantial outpatient gastroenterology capacity.

Indiana benefits from Indianapolis and expanding regional provider systems. Missouri has major markets in St. Louis and Kansas City, while Iowa and Kansas provide stable demand from regional hospitals and physician-owned centers.

Nebraska, North Dakota, and South Dakota are smaller markets with significant rural catchment areas. These states benefit from hub-and-spoke referral models and technologies that can be supported across dispersed facilities. Single-use bronchoscopy, portable endoscopy, and dependable service arrangements can be commercially attractive.

The Midwest is expected to remain a reliable market for reusable platforms, standard endotherapy accessories, reprocessing systems, and replacement equipment. Manufacturers often gain share through service performance, clinician education, enterprise contracting, and long-term health-system relationships.

 

Key Market Players

The U.S. Endoscopy Devices Competitive Landscape is moderately consolidated in capital equipment and more fragmented in accessories, single-use products, artificial intelligence, robotic navigation, and therapeutic technologies.

Olympus, Stryker, KARL STORZ, Fujifilm, and PENTAX Medical maintain substantial positions in visualization and reusable endoscopy. Boston Scientific, Cook Medical, Micro-Tech, Medtronic, ERBE, and other specialty suppliers compete across therapeutic devices and accessories. Ambu has established a strong position in single-use endoscopy, while Intuitive Surgical, Noah Medical, and emerging robotics companies are expanding competition in navigational and endoluminal systems.

Some of the key players operating in the U.S. Endoscopy Devices industry are:

1. Olympus Corporation
2. Boston Scientific Corporation
3. Stryker Corporation
4. KARL STORZ
5. Fujifilm Healthcare Americas Corporation
6. PENTAX Medical, a HOYA Corporation company
7. Medtronic
8. Johnson & Johnson MedTech and Ethicon
9. Ambu A/S
10. CONMED Corporation
11. Cook Medical
12. Intuitive Surgical
13. Richard Wolf GmbH
14. B. Braun and Aesculap
15. Smith+Nephew
16. STERIS
17. ERBE USA
18. Micro-Tech Endoscopy USA
19. Merit Medical Systems
20. Teleflex Incorporated
21. Medline Industries
22. Creo Medical
23. EndoQuest Robotics
24. Noah Medical

Competition is increasingly platform-based. Large manufacturers can bundle scopes, processors, surgical cameras, instruments, service, artificial intelligence, and reprocessing support. Their scale provides advantages in training, repair networks, loaner fleets, regulatory infrastructure, contracting, and clinical evidence.

Specialized competitors can gain share by solving a focused clinical or economic problem. Examples include eliminating reprocessing, improving access to peripheral lung lesions, reducing gastrointestinal bleeding, enabling endoscopic suturing, simplifying tissue closure, or lowering reusable-scope repair exposure.

Market share through 2035 will be influenced by platform replacement cycles, FDA clearances, artificial intelligence performance, physician preference, service reliability, supply availability, health-system contracting, sustainability requirements, cybersecurity, and clinical evidence.

 

Recent Developments

Recent developments in the U.S. Endoscopy Devices Market demonstrate strong investment in next-generation visualization, therapeutic accessories, artificial intelligence, robotic bronchoscopy, and single-use technology.

Olympus reported continued growth in its endoscopic solutions business during the fiscal year ending March 2025, with North American demand supported by the EVIS X1 gastrointestinal endoscopy platform and surgical system-integration products. This illustrates the ongoing U.S. replacement cycle for advanced imaging systems and the commercial importance of integrated platforms.

Boston Scientific reported global endoscopy revenue of approximately USD 2.69 billion in 2024, with organic growth of about 8%. Its performance reflects continued demand for gastrointestinal therapeutic devices, including stents, hemostasis products, tissue-acquisition technologies, and single-use imaging products.

Single-use endoscopy continued to expand during 2024 and 2025. Adoption was strongest in respiratory and urology applications, while gastrointestinal penetration remained comparatively low. Manufacturers are increasingly positioning disposable scopes around workflow availability, infection prevention, repair avoidance, and reduction of reprocessing burden rather than sterility alone.

In 2025, Intuitive Surgical received U.S. regulatory clearance for software advancements incorporating artificial intelligence across the Ion robotic bronchoscopy navigation workflow. The development demonstrates how artificial intelligence and advanced imaging are becoming integrated into pulmonary diagnostic platforms.

Artificial intelligence-assisted colonoscopy also continued to gain commercial traction as providers evaluated computer-aided detection within quality-improvement programs. Procurement decisions increasingly consider adenoma-detection performance, false-positive burden, workflow integration, software cost, and compatibility with installed imaging systems.

FDA attention to reusable-device reprocessing continued to influence scope design and hospital purchasing. Manufacturers have responded through disposable components, revised cleaning instructions, redesigned endoscopes, surveillance programs, enhanced drying, and single-use alternatives.

CMS updated hospital outpatient and ambulatory surgery center payment policies for 2025, maintaining reimbursement visibility for many outpatient endoscopic procedures. Annual payment updates remain important because procedure migration and site-of-service economics influence purchasing decisions across hospitals and independent ASCs.

Sustainability has also become a more prominent procurement consideration. Single-use manufacturers are developing collection and recycling programs, while reusable-platform suppliers are emphasizing durability, repairability, water efficiency, chemical management, and extended equipment life. Health systems increasingly require environmental claims to be supported by transparent lifecycle analysis.

The competitive landscape is expected to remain active in mergers, partnerships, software integration, and portfolio expansion. Large medtech companies are likely to seek technologies that strengthen their positions in artificial intelligence, therapeutic endoscopy, robotic navigation, tissue closure, and outpatient care.

 

Conclusion

The U.S. Endoscopy Devices Market is positioned to expand from approximately USD 18.95 billion in 2025 to USD 41.77 billion by 2035, representing a CAGR of 8.22% during the 2026–2035 forecast period.

The market’s long-term growth is supported by more than 20 million annual gastrointestinal endoscopic procedures, an expanding colorectal screening population, increasing ambulatory care utilization, aging demographics, obesity-related disease, lung-cancer diagnosis, and the continuing movement from open surgery toward minimally invasive and endoluminal treatment.

Gastrointestinal endoscopy will remain the largest clinical application, but the highest growth opportunities will be found in artificial intelligence-assisted detection, therapeutic endoscopy, single-use scopes, robotic bronchoscopy, advanced tissue acquisition, endoscopic suturing, capsule endoscopy, fluorescence imaging, and automated reprocessing.

Hospitals will remain the largest end users, while ambulatory surgery centers will capture a rising share of procedure and device demand. Procurement will increasingly be based on total cost per case, room throughput, clinical outcomes, repair exposure, infection-control burden, staff efficiency, and reimbursement alignment.

The South will remain the largest regional market because of population scale and disease burden. The West will grow fastest because of technology adoption and population expansion. The Northeast will remain highly influential in advanced clinical adoption, while the Midwest will provide stable demand supported by established hospital and ambulatory networks.

For manufacturers, investors, distributors, and healthcare providers, the central strategic issue is not simply whether endoscopy volumes will increase. The more important questions are which procedures will shift to outpatient settings, where disposable technology will replace reusable devices, how artificial intelligence will affect platform selection, and which therapeutic procedures will move care away from surgery.

Companies that combine superior visualization, therapeutic capability, reliable service, workflow integration, clinical evidence, and credible health-economic value will define the competitive direction of the U.S. endoscopy devices industry through 2035.

 

TABLE OF CONTENT

1. U.S. Endoscopy Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.2.1. Devices and Technologies Included in the Market
1.2.2. Clinical Applications Included in the Market
1.2.3. Revenue Streams Included in the Market
1.2.4. Market Exclusions
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Bottom-Up Market Estimation
1.3.6. Top-Down Market Validation
1.3.7. Procedure-Volume and Installed-Base Modeling
1.3.8. Average Selling Price Analysis
1.3.9. Analytical Frameworks & Forecasting Models
1.3.10. Data Triangulation, Validation and Final Report Publishing
1.4. Base Year, Historical Period and Forecast Period
1.4.1. Historical Period, 2021–2024
1.4.2. Base Year, 2025
1.4.3. Forecast Period, 2026–2035
1.5. Key Market Assumptions
1.5.1. Endoscopic Procedure-Volume Assumptions
1.5.2. Capital Equipment Replacement-Cycle Assumptions
1.5.3. Reusable and Single-Use Device Adoption Assumptions
1.5.4. Endotherapy Consumables Utilization Assumptions
1.5.5. Hospital and Ambulatory Procedure Migration Assumptions
1.6. Market Ecosystem Overview
1.7. Stakeholder Analysis
1.7.1. Endoscope and Visualization-System Manufacturers
1.7.2. Endotherapy Device and Accessory Manufacturers
1.7.3. Endoscope Reprocessing and Infection-Prevention Suppliers
1.7.4. Component Manufacturers and Contract Manufacturing Organizations
1.7.5. Hospitals and Integrated Delivery Networks
1.7.6. Ambulatory Surgery Centers
1.7.7. Gastroenterology and Specialty Endoscopy Centers
1.7.8. Academic Medical Centers and Research Institutions
1.7.9. Group Purchasing Organizations
1.7.10. Medical Device Distributors and Specialty Suppliers
1.7.11. Payers and Reimbursement Authorities
1.7.12. Regulators, Accreditation Bodies and Clinical Associations

What this section provides: This chapter defines the U.S. Endoscopy Devices Market boundary, study scope, methodology, market inclusions, exclusions, assumptions, measurement framework, and stakeholder ecosystem so clients understand how historical values and forecasts are developed and validated.

2. U.S. Endoscopy Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. U.S. Endoscopy Devices Market Size, 2021–2035
2.3. Historical Market Summary, 2021–2024
2.4. Base Year Market Positioning, 2025
2.5. Forecast Outlook, 2026–2035
2.6. Market CAGR Analysis, 2026–2035
2.7. Analyst Viewpoint
2.8. Market Attractiveness Index
2.8.1. Attractiveness by Product Category
2.8.2. Attractiveness by Application
2.8.3. Attractiveness by End User
2.8.4. Attractiveness by Technology Type
2.8.5. Attractiveness by Procurement Channel
2.8.6. Attractiveness by Geography
2.9. Largest Revenue-Contributing Segments
2.10. Fastest-Growing Segments
2.11. High-Growth Opportunity Areas
2.11.1. Artificial Intelligence-Assisted Endoscopy
2.11.2. Single-Use Endoscopy
2.11.3. Therapeutic and Interventional Endoscopy
2.11.4. Robotic and Navigational Bronchoscopy
2.11.5. Endoscopic Suturing and Tissue Closure
2.11.6. Automated Endoscope Reprocessing
2.12. Key Strategic Findings for Market Participants

What this section provides: This chapter gives decision-makers a concise view of market size, CAGR, historical development, forecast direction, segment attractiveness, technology priorities, competitive intensity, and the most commercially important opportunities through 2035.

3. U.S. Endoscopy Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Expanding Colorectal Cancer Screening Population
3.1.2. High Volume of Gastrointestinal Endoscopic Procedures
3.1.3. Rising Incidence of Gastrointestinal, Pulmonary and Urological Disorders
3.1.4. Shift from Open Surgery to Minimally Invasive and Endoluminal Procedures
3.1.5. Expansion of Therapeutic and Interventional Endoscopy
3.1.6. Growth of Ambulatory Surgery Centers and Specialty Endoscopy Facilities
3.1.7. Replacement of Aging Endoscopy and Visualization Platforms
3.1.8. Adoption of High-Definition, 4K and Advanced Imaging Systems
3.1.9. Growing Use of Artificial Intelligence-Assisted Lesion Detection
3.1.10. Rising Demand for Single-Use Endoscopes
3.1.11. Increased Pulmonary Nodule Detection and Lung Cancer Screening
3.1.12. Aging U.S. Population and Medicare Procedure Demand
3.1.13. Growing Obesity Burden and Bariatric Endoscopy Adoption
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Advanced Endoscopy Platforms
3.2.2. High Repair and Maintenance Cost of Reusable Endoscopes
3.2.3. Complex Endoscope Cleaning and Reprocessing Requirements
3.2.4. Reimbursement Pressure and Site-of-Service Payment Differences
3.2.5. Product Recall, Contamination and Patient-Safety Risks
3.2.6. Gastroenterologist and Advanced Endoscopist Workforce Constraints
3.2.7. Sustainability Concerns Related to Single-Use Devices
3.2.8. Budget Constraints Among Rural and Community Hospitals
3.3. Opportunities and Their Impact Analysis
3.3.1. Artificial Intelligence-Assisted Colonoscopy and Image Interpretation
3.3.2. Single-Use Bronchoscope, Cystoscope and Ureteroscope Adoption
3.3.3. Robotic and Navigational Bronchoscopy Expansion
3.3.4. Advanced Polypectomy and Endoscopic Resection
3.3.5. Endoscopic Suturing, Tissue Closure and Bariatric Endoscopy
3.3.6. Capsule Endoscopy and Remote Diagnostic Workflows
3.3.7. Automated Reprocessing, Drying and Traceability Systems
3.3.8. Ambulatory and Office-Based Endoscopy Expansion
3.3.9. Subscription-Based Software and AI Commercial Models
3.3.10. Enterprise Endoscopy Platform Standardization
3.4. Challenges and Their Impact Analysis
3.4.1. Demonstrating Clinical and Economic Value
3.4.2. Balancing Reusable and Single-Use Device Economics
3.4.3. Technology Integration with Legacy Imaging Systems
3.4.4. Physician Training and Learning-Curve Requirements
3.4.5. Cybersecurity and Patient Data Integration
3.4.6. Supply-Chain and Component Availability
3.4.7. Managing Capital and Consumables Contract Complexity
3.5. Patent & Innovation Analysis, 2021–2025
3.5.1. Artificial Intelligence and Computer-Aided Detection Patents
3.5.2. Robotic Endoscopy and Navigation Patents
3.5.3. Single-Use Endoscope Design Patents
3.5.4. Therapeutic Endoscopy and Tissue-Closure Patents
3.5.5. Advanced Visualization and Optical Imaging Patents
3.5.6. Reprocessing and Infection-Prevention Patents
3.6. Clinical Workflow Economics Analysis
3.6.1. Cost per Endoscopic Procedure
3.6.2. Procedure-Room Turnover Economics
3.6.3. Reprocessing Labor and Consumables Cost
3.6.4. Scope Repair and Downtime Economics
3.6.5. Capital Equipment Utilization
3.6.6. Endotherapy Consumables Utilization
3.6.7. Hospital Versus Ambulatory Procedure Economics
3.7. Hospital Capital Procurement Behavior Analysis
3.7.1. Capital Budget Approval Process
3.7.2. Physician Preference and Clinical Evaluation
3.7.3. Value Analysis Committee Requirements
3.7.4. Enterprise Platform Standardization
3.7.5. Service Contract and Repair Program Evaluation
3.7.6. Total Cost of Ownership Assessment
3.8. Reprocessing and Infection-Control Economics
3.8.1. Manual Cleaning and High-Level Disinfection
3.8.2. Automated Endoscope Reprocessing
3.8.3. Drying, Storage and Transportation
3.8.4. Reprocessing Documentation and Traceability
3.8.5. Reusable Versus Single-Use Cost Comparison

What this section provides: This chapter explains the clinical, economic, reimbursement, operational and technological forces shaping demand, enabling clients to evaluate growth catalysts, market barriers, investment opportunities, adoption risks, workflow economics and purchasing behavior.

4. U.S. Endoscopy Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political Factors
4.1.2. Economic Factors
4.1.3. Social Factors
4.1.4. Technological Factors
4.1.5. Environmental Factors
4.1.6. Legal Factors
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitution
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis, 2025–2035
4.3.1. Flexible Endoscope Pricing
4.3.2. Rigid Endoscope Pricing
4.3.3. Visualization-System Pricing
4.3.4. Endotherapy Device Pricing
4.3.5. Single-Use Endoscope Pricing
4.3.6. Reprocessing-System Pricing
4.3.7. Regional Pricing Differences
4.4. Value Chain Analysis
4.4.1. Raw Materials and Precision Components
4.4.2. Optical, Sensor and Imaging Components
4.4.3. Device Manufacturing and Assembly
4.4.4. Regulatory Clearance and Quality Management
4.4.5. Distribution and Logistics
4.4.6. Hospital and Ambulatory Procurement
4.4.7. Clinical Utilization and After-Sales Service
4.5. Supply Chain Analysis
4.5.1. Semiconductor and Imaging-Sensor Supply
4.5.2. Specialty Polymer and Metal Component Supply
4.5.3. Contract Manufacturing Dependence
4.5.4. Sterilization and Packaging Capacity
4.5.5. Inventory and Distribution Resilience
4.6. Impact of Digitalization and Connected Endoscopy
4.6.1. Digital Image Management
4.6.2. Procedure Documentation Systems
4.6.3. Electronic Health Record Integration
4.6.4. Remote Collaboration and Tele-Proctoring
4.6.5. Cloud-Based Quality Analytics
4.7. Application & Innovation Landscape
4.8. FDA Regulatory Framework Analysis
4.8.1. Premarket Notification Pathway
4.8.2. Premarket Approval Pathway
4.8.3. De Novo Classification Pathway
4.8.4. Software and Artificial Intelligence Regulation
4.8.5. Single-Use Device Regulatory Considerations
4.8.6. Post-Market Surveillance and Recall Requirements
4.9. Endoscope Reprocessing Standards and Compliance Landscape
4.9.1. Reprocessing Instructions for Use
4.9.2. High-Level Disinfection Requirements
4.9.3. Sterilization Requirements for Critical Devices
4.9.4. Drying and Storage Requirements
4.9.5. Accreditation and Facility Compliance
4.10. CMS Reimbursement and Coverage Landscape
4.10.1. Hospital Inpatient Reimbursement
4.10.2. Hospital Outpatient Reimbursement
4.10.3. Ambulatory Surgery Center Reimbursement
4.10.4. Physician Fee Schedule Considerations
4.10.5. Screening Colonoscopy Coverage
4.10.6. Technology-Specific Reimbursement Considerations
4.11. Import, Export, Tariff and Trade Impact
4.12. Government Screening and Public Health Initiatives
4.12.1. Colorectal Cancer Screening Initiatives
4.12.2. Lung Cancer Screening Initiatives
4.12.3. Infection-Prevention and Patient-Safety Programs
4.13. Sustainability and Environmental Impact Analysis
4.13.1. Reusable Device Water and Chemical Consumption
4.13.2. Single-Use Device Waste Generation
4.13.3. Device Recycling and Recovery Programs
4.13.4. Lifecycle Assessment in Procurement
4.14. Impact of Escalating Geopolitical Tensions
4.15. Hospital Value Analysis Committee Decision Framework
4.15.1. Clinical Evidence Evaluation
4.15.2. Procedural Efficiency Evaluation
4.15.3. Infection-Control Evaluation
4.15.4. Financial and Reimbursement Evaluation
4.15.5. Service, Repair and Supply Reliability Evaluation

What this section provides: This chapter gives clients a comprehensive view of the external market environment, including regulation, reimbursement, pricing, competition, supply chains, digitalization, reprocessing compliance, sustainability and hospital value-analysis requirements.

5. U.S. Endoscopy Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
5.2. Endoscopes
5.2.1. Gastrointestinal Endoscopes
5.2.1.1. Colonoscopes
5.2.1.2. Gastroscopes
5.2.1.3. Duodenoscopes
5.2.1.4. Enteroscopes
5.2.1.5. Echoendoscopes
5.2.1.6. Specialty Therapeutic Endoscopes
5.2.2. Bronchoscopes
5.2.3. Cystoscopes and Ureteroscopes
5.2.4. Laparoscopes
5.2.5. Arthroscopes
5.2.6. Hysteroscopes
5.2.7. ENT Endoscopes
5.2.8. Capsule Endoscopes
5.2.9. Other Specialty Endoscopes
5.3. Visualization and Imaging Systems
5.3.1. Video Processors
5.3.2. Camera Control Units
5.3.3. Camera Heads
5.3.4. Light Sources
5.3.5. Medical-Grade Monitors
5.3.6. Image-Management and Recording Systems
5.3.7. Endoscopy Carts and Integrated Room Systems
5.3.8. Endoscopy Software Platforms
5.4. Endotherapy Devices and Procedure Accessories
5.4.1. Biopsy Forceps
5.4.2. Polypectomy Snares
5.4.3. Guidewires
5.4.4. Dilation Balloons
5.4.5. Retrieval Devices and Baskets
5.4.6. Endoscopic Clips
5.4.7. Injection Needles
5.4.8. Cytology Brushes
5.4.9. Endoscopic Stents
5.4.10. Sphincterotomes
5.4.11. Hemostasis Devices
5.4.12. Endoscopic Suturing Systems
5.4.13. Tissue-Closure Devices
5.4.14. Endoscopic Ultrasound Needles
5.4.15. Valves, Caps and Tubing
5.4.16. Other Endotherapy Accessories
5.5. Insufflation, Fluid-Management and Electrosurgical Systems
5.5.1. Insufflators
5.5.2. Irrigation Pumps
5.5.3. Fluid-Management Systems
5.5.4. Electrosurgical Generators
5.5.5. Argon Plasma Coagulation Systems
5.5.6. Smoke-Evacuation Systems
5.5.7. Suction Systems
5.5.8. Disposable Tubing and Procedure Packs
5.6. Reprocessing, Storage, Service and Infection-Prevention Products
5.6.1. Automated Endoscope Reprocessors
5.6.2. Manual Cleaning Equipment
5.6.3. Leak Testing Systems
5.6.4. Drying and Storage Cabinets
5.6.5. Transport and Containment Systems
5.6.6. Detergents and High-Level Disinfectants
5.6.7. Reprocessing Tracking Software
5.6.8. Repair, Maintenance and Service Contracts

What this section provides: This chapter identifies which endoscopy product categories and subcategories are expected to generate the largest revenue contribution, strongest recurring consumables demand, highest replacement activity and fastest growth through 2035.

6. U.S. Endoscopy Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
6.2. Gastrointestinal Endoscopy
6.2.1. Colonoscopy and Colorectal Cancer Screening
6.2.2. Upper Gastrointestinal Endoscopy
6.2.3. Endoscopic Retrograde Cholangiopancreatography
6.2.4. Endoscopic Ultrasound
6.2.5. Enteroscopy and Small-Bowel Evaluation
6.2.6. Gastrointestinal Bleeding Management
6.2.7. Advanced Polypectomy and Endoscopic Mucosal Resection
6.2.8. Endoscopic Submucosal Dissection
6.2.9. Endoscopic Suturing and Tissue Closure
6.2.10. Bariatric and Metabolic Endoscopy
6.2.11. Capsule Endoscopy
6.3. Laparoscopy and General Surgery
6.3.1. Cholecystectomy
6.3.2. Hernia Repair
6.3.3. Bariatric Surgery
6.3.4. Colorectal Surgery
6.3.5. Appendectomy
6.3.6. Anti-Reflux Surgery
6.3.7. Thoracoscopy
6.3.8. Other Minimally Invasive Surgical Procedures
6.4. Pulmonology and Bronchoscopy
6.4.1. Diagnostic Bronchoscopy
6.4.2. Intensive-Care and Emergency Bronchoscopy
6.4.3. Endobronchial Ultrasound
6.4.4. Peripheral Pulmonary Nodule Biopsy
6.4.5. Robotic and Navigational Bronchoscopy
6.4.6. Airway Management and Therapeutic Bronchoscopy
6.5. Urology
6.5.1. Diagnostic Cystoscopy
6.5.2. Ureteroscopy
6.5.3. Stone Management
6.5.4. Bladder Tumor Evaluation and Treatment
6.5.5. Nephroscopy
6.5.6. Resection and Other Urological Procedures
6.6. ENT, Gynecology, Arthroscopy and Other Applications
6.6.1. ENT Endoscopy
6.6.2. Hysteroscopy
6.6.3. Arthroscopy
6.6.4. Neurosurgical Endoscopy
6.6.5. Spine Endoscopy
6.6.6. Other Specialty Applications

What this section provides: This chapter explains endoscopy-device demand by clinical procedure and use case, helping clients identify applications with strong procedure growth, favorable outpatient migration, recurring consumables demand and high-value technology adoption.

7. U.S. Endoscopy Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
7.2. Hospitals and Integrated Health Systems
7.2.1. Academic Hospitals
7.2.2. Tertiary and Quaternary Hospitals
7.2.3. Community Hospitals
7.2.4. Rural Hospitals
7.2.5. Veterans and Government Hospitals
7.3. Ambulatory Surgery Centers
7.3.1. Gastroenterology-Focused ASCs
7.3.2. Multispecialty ASCs
7.3.3. Hospital-Owned ASCs
7.3.4. Physician-Owned ASCs
7.3.5. Private Equity-Backed ASC Platforms
7.4. Specialty Endoscopy Centers and Physician-Owned Clinics
7.4.1. Gastroenterology Practices
7.4.2. Pulmonology Practices
7.4.3. Urology Practices
7.4.4. ENT Practices
7.4.5. Women’s Health and Gynecology Clinics
7.5. Academic Medical Centers and Research Institutions
7.5.1. Advanced Endoscopy Centers
7.5.2. Clinical Trial Sites
7.5.3. Fellowship and Physician Training Centers
7.5.4. Innovation and Translational Research Centers
7.6. Office-Based Facilities and Other Care Settings
7.6.1. Office-Based Procedure Suites
7.6.2. Emergency Departments
7.6.3. Intensive-Care Units
7.6.4. Diagnostic Centers
7.6.5. Mobile and Remote Care Settings

What this section provides: This chapter evaluates which care settings and customer groups drive capital equipment purchasing, recurring procedure-device utilization, reprocessing demand and adoption of advanced endoscopy technologies.

8. U.S. Endoscopy Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
8.2. Reusable Endoscopy Platforms
8.2.1. Reusable Flexible Endoscopes
8.2.2. Reusable Rigid Endoscopes
8.2.3. Reusable Visualization Platforms
8.2.4. Reusable Therapeutic Platforms
8.3. Single-Use Endoscopy
8.3.1. Single-Use Bronchoscopes
8.3.2. Single-Use Cystoscopes
8.3.3. Single-Use Ureteroscopes
8.3.4. Single-Use Duodenoscopes
8.3.5. Single-Use ENT Endoscopes
8.3.6. Other Single-Use Endoscopes
8.4. High-Definition, 4K and Three-Dimensional Visualization
8.4.1. High-Definition Imaging
8.4.2. 4K Imaging
8.4.3. Three-Dimensional Visualization
8.4.4. Fluorescence Imaging
8.4.5. Enhanced Contrast and Spectral Imaging
8.5. Artificial Intelligence and Advanced Imaging
8.5.1. Computer-Aided Detection
8.5.2. Computer-Aided Diagnosis
8.5.3. Lesion Characterization
8.5.4. Procedure Quality Analytics
8.5.5. Capsule Endoscopy Interpretation
8.5.6. AI-Assisted Bronchoscopy Navigation
8.6. Robotic, Navigational and Capsule Endoscopy
8.6.1. Robotic Bronchoscopy
8.6.2. Electromagnetic Navigation
8.6.3. Shape-Sensing Navigation
8.6.4. Endoluminal Robotic Systems
8.6.5. Capsule Endoscopy
8.6.6. Emerging Autonomous and Semi-Autonomous Systems

What this section provides: This chapter evaluates the technology platforms transforming endoscopy, including reusable and disposable devices, advanced visualization, artificial intelligence, robotic navigation and capsule-based diagnostic systems.

9. U.S. Endoscopy Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
9.2. Direct Hospital and Health System Procurement
9.2.1. Capital Equipment Procurement
9.2.2. Consumables and Accessories Procurement
9.2.3. Service and Repair Contracts
9.2.4. Reprocessing Equipment Procurement
9.3. Integrated Delivery Network Enterprise Contracts
9.3.1. Enterprise Platform Standardization
9.3.2. Multiyear Technology Agreements
9.3.3. Capital-Consumables Bundling
9.3.4. System-Wide Service Agreements
9.4. Group Purchasing Organization Contracts
9.4.1. National GPO Agreements
9.4.2. Regional GPO Agreements
9.4.3. Aggregated ASC Purchasing
9.4.4. Contract Compliance and Tiered Pricing
9.5. Distributor and Specialty Supplier Sales
9.5.1. National Medical Device Distributors
9.5.2. Regional Specialty Distributors
9.5.3. Endoscopy Accessory Distributors
9.5.4. Reprocessing and Infection-Control Distributors
9.6. Ambulatory and Physician-Owned Facility Procurement
9.6.1. Direct Manufacturer Purchases
9.6.2. Leasing and Equipment Financing
9.6.3. Procedure-Based Pricing Agreements
9.6.4. Scope Rental and Managed-Service Models
9.6.5. Private Equity Platform Procurement

What this section provides: This chapter explains how endoscopy devices are purchased in the United States, including direct hospital contracting, IDN standardization, GPO influence, distributor participation, leasing, managed-service models and ambulatory procurement behavior.

10. U.S. Endoscopy Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Endoscopic Procedure-Volume Analysis
10.1.4. Regional Hospital and Ambulatory Infrastructure Analysis
10.1.5. Regional Colorectal Cancer Screening and Disease-Burden Analysis
10.1.6. Regional Reimbursement and Payer-Mix Analysis
10.1.7. Regional Procurement and Technology-Adoption Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This chapter delivers detailed regional and state-level market analysis across all 50 states, helping clients identify procedure-volume hubs, installed-base concentrations, screening opportunities, outpatient growth markets, technology-adoption hotspots and state-level commercial priorities.

11. U.S. Endoscopy Devices Market: Competitive Landscape & Company Profiles

11.1. Competitive Landscape Overview
11.2. Market Share Analysis, 2025
11.2.1. Market Share by Endoscopy Platform Provider
11.2.2. Market Share by Endotherapy Device Provider
11.2.3. Market Share by Single-Use Endoscopy Provider
11.2.4. Market Share by Reprocessing-System Provider
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Competitive Benchmarking
11.4.1. Product Portfolio Breadth
11.4.2. U.S. Installed Base
11.4.3. Clinical Evidence
11.4.4. Artificial Intelligence Capabilities
11.4.5. Single-Use Device Capabilities
11.4.6. Service and Repair Infrastructure
11.4.7. Distribution and Hospital Contracting Strength
11.4.8. Regulatory and Innovation Pipeline
11.5. Strategic Developments, 2021–2025
11.5.1. Product Launches
11.5.2. FDA Clearances and Approvals
11.5.3. Mergers and Acquisitions
11.5.4. Partnerships and Collaborations
11.5.5. Clinical Trials and Evidence Generation
11.5.6. U.S. Manufacturing and Distribution Expansion
11.6. Company Profiles

11.6.1. Olympus Corporation
11.6.2. Boston Scientific Corporation
11.6.3. Stryker Corporation
11.6.4. KARL STORZ
11.6.5. Fujifilm Healthcare Americas Corporation
11.6.6. PENTAX Medical, a HOYA Corporation Company
11.6.7. Medtronic
11.6.8. Johnson & Johnson MedTech and Ethicon
11.6.9. Ambu A/S
11.6.10. CONMED Corporation
11.6.11. Cook Medical
11.6.12. Intuitive Surgical
11.6.13. Richard Wolf GmbH
11.6.14. B. Braun and Aesculap
11.6.15. Smith+Nephew
11.6.16. STERIS
11.6.17. ERBE USA
11.6.18. Micro-Tech Endoscopy USA
11.6.19. Merit Medical Systems
11.6.20. Teleflex Incorporated
11.6.21. Medline Industries
11.6.22. Creo Medical
11.6.23. EndoQuest Robotics
11.6.24. Noah Medical

Note: Each company profile will include company overview, U.S. endoscopy-device portfolio, product-category presence, application coverage, financial positioning, U.S. commercial strategy, distribution structure, installed-base position, clinical pipeline, regulatory updates, partnerships, mergers and acquisitions, and recent developments.

What this section provides: This chapter gives clients market-share visibility, competitor benchmarking, portfolio positioning, innovation direction, commercial strategy analysis and detailed intelligence on 24 major and emerging companies operating in the U.S. Endoscopy Devices Market.

12. U.S. Endoscopy Devices Market: Future Market Outlook, 2026–2035

12.1. Market Evolution Through 2035
12.2. Scenario Analysis
12.2.1. Optimistic Scenario
12.2.2. Realistic Scenario
12.2.3. Pessimistic Scenario
12.3. Forecast Sensitivity Analysis
12.3.1. Procedure-Volume Sensitivity
12.3.2. Capital Replacement-Cycle Sensitivity
12.3.3. Single-Use Adoption Sensitivity
12.3.4. Reimbursement Sensitivity
12.3.5. Average Selling Price Sensitivity
12.4. Disruptive Technologies Impact
12.4.1. Artificial Intelligence-Assisted Detection and Diagnosis
12.4.2. Single-Use Endoscopy Platforms
12.4.3. Robotic and Navigational Bronchoscopy
12.4.4. Endoluminal Robotic Surgery
12.4.5. Advanced Therapeutic Endoscopy
12.4.6. Endoscopic Suturing and Tissue Closure
12.4.7. Capsule Endoscopy and Remote Diagnostics
12.4.8. Automated Reprocessing and Traceability
12.4.9. Fluorescence and Molecular Imaging
12.5. Emerging Clinical and Business Trends
12.5.1. Migration of Procedures to Ambulatory Settings
12.5.2. Growth of Private Equity-Backed Endoscopy Platforms
12.5.3. Enterprise Technology Standardization
12.5.4. Software Subscription and Per-Procedure Models
12.5.5. Sustainability-Based Procurement
12.5.6. Value-Based Contracting
12.6. Business Opportunities for Startups and Existing Players
12.7. Investment Prioritization Matrix
12.7.1. High-Growth, High-Competition Opportunities
12.7.2. High-Growth, Lower-Penetration Opportunities
12.7.3. Mature, Defensible Revenue Categories
12.7.4. Emerging Long-Term Technology Bets
12.8. White-Space Opportunity Analysis
12.9. Market Entry Timing Analysis

What this section provides: This chapter prepares clients for future changes in technology, clinical practice, site of care, market structure and reimbursement while identifying investment priorities, disruptive opportunities and realistic adoption scenarios through 2035.

13. U.S. Endoscopy Devices Market: Strategic Recommendations

13.1. Recommendations for Endoscopy Device Manufacturers
13.1.1. Portfolio Prioritization
13.1.2. Platform and Consumables Integration
13.1.3. Clinical Evidence Development
13.1.4. Service and Repair Differentiation
13.1.5. Artificial Intelligence Commercialization
13.1.6. Single-Use Product Strategy
13.2. Recommendations for Hospitals and Integrated Health Systems
13.2.1. Enterprise Platform Standardization
13.2.2. Total Cost of Ownership Evaluation
13.2.3. Reprocessing Capacity Planning
13.2.4. Artificial Intelligence Adoption Framework
13.2.5. Reusable and Single-Use Utilization Strategy
13.3. Recommendations for Ambulatory Surgery Centers
13.3.1. Capital Equipment Selection
13.3.2. Procedure-Room Throughput Optimization
13.3.3. Service Contract Evaluation
13.3.4. Consumables Cost Management
13.3.5. Leasing and Managed-Service Models
13.4. Recommendations for Investors and Private Equity Firms
13.4.1. High-Growth Technology Categories
13.4.2. ASC and Physician-Practice Consolidation Opportunities
13.4.3. Recurring Revenue and Consumables Models
13.4.4. Platform Versus Specialty Device Investment Strategy
13.5. Recommendations for Distributors and Channel Partners
13.5.1. Specialty Portfolio Development
13.5.2. Regional Service Coverage
13.5.3. Community Hospital and Rural Market Strategy
13.5.4. Ambulatory Market Expansion
13.6. Recommendations for New Entrants and Startups
13.6.1. Regulatory Pathway Planning
13.6.2. Clinical Evidence and Key Opinion Leader Strategy
13.6.3. Reimbursement and Economic Value Strategy
13.6.4. Channel and Partnership Strategy
13.7. Go-to-Market Strategy Considerations
13.7.1. Hospital Market Entry
13.7.2. ASC Market Entry
13.7.3. Physician-Practice Market Entry
13.7.4. Regional Commercialization Strategy
13.8. Product Positioning and Portfolio Expansion Guidance
13.9. Partnership, Licensing and Acquisition Strategy
13.10. U.S. Market Risk-Mitigation Framework

What this section provides: This chapter converts the market intelligence into actionable recommendations for product strategy, market entry, clinical evidence, pricing, procurement engagement, channel expansion, investment planning and competitive differentiation.

14. U.S. Endoscopy Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition Limitation
14.3. Data Availability Limitation
14.4. Data Use Limitation
14.5. Forecasting Limitation
14.6. Procedure-Volume Estimation Limitation
14.7. State-Level Market Estimation Limitation
14.8. Company and Market Share Limitation
14.9. Regulatory and Reimbursement Limitation
14.10. Currency and Inflation Limitation
14.11. Legal Disclaimer
14.12. Third-Party Data Disclaimer

What this section provides: This chapter clarifies the report’s analytical limitations, legal boundaries, data-use conditions, forecast assumptions, state-level estimation methodology and the treatment of regulatory, reimbursement and third-party information.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Endoscopy Devices Market: Market Definition and Scope
TABLE 3: U.S. Endoscopy Devices Market: Devices, Applications and Revenue Streams Included
TABLE 4: U.S. Endoscopy Devices Market: Research Methodology Framework
TABLE 5: U.S. Endoscopy Devices Market: Market Estimation and Data Validation Framework
TABLE 6: U.S. Endoscopy Devices Market: Key Assumptions
TABLE 7: U.S. Endoscopy Devices Market: Market Ecosystem Overview
TABLE 8: U.S. Endoscopy Devices Market: Stakeholder Analysis
TABLE 9: U.S. Endoscopy Devices Market: Executive Summary Snapshot, 2025
TABLE 10: U.S. Endoscopy Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Endoscopy Devices Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Endoscopy Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Endoscopy Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 14: U.S. Endoscopy Devices Market: Market Attractiveness Index
TABLE 15: U.S. Endoscopy Devices Market: High-Growth Opportunity Areas
TABLE 16: U.S. Endoscopy Devices Market: Drivers and Impact Analysis
TABLE 17: U.S. Endoscopy Devices Market: Restraints and Impact Analysis
TABLE 18: U.S. Endoscopy Devices Market: Opportunities and Impact Analysis
TABLE 19: U.S. Endoscopy Devices Market: Challenges and Impact Analysis
TABLE 20: U.S. Endoscopy Devices Market: Patent and Innovation Analysis, 2021–2025
TABLE 21: U.S. Endoscopy Devices Market: Clinical Workflow Economics Matrix
TABLE 22: U.S. Endoscopy Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 23: U.S. Endoscopy Devices Market: Reprocessing and Infection-Control Economics
TABLE 24: U.S. Endoscopy Devices Market: Reusable Versus Single-Use Cost Comparison
TABLE 25: U.S. Endoscopy Devices Market: PESTEL Analysis
TABLE 26: U.S. Endoscopy Devices Market: Porter’s Five Forces Analysis
TABLE 27: U.S. Endoscopy Devices Market: Pricing Trend Analysis, 2025–2035
TABLE 28: U.S. Endoscopy Devices Market: Value Chain Analysis
TABLE 29: U.S. Endoscopy Devices Market: Supply Chain Analysis
TABLE 30: U.S. Endoscopy Devices Market: Digitalization and Connected Endoscopy Impact
TABLE 31: U.S. Endoscopy Devices Market: Application and Innovation Landscape
TABLE 32: U.S. Endoscopy Devices Market: FDA Regulatory Framework Analysis
TABLE 33: U.S. Endoscopy Devices Market: Endoscope Reprocessing Standards and Compliance
TABLE 34: U.S. Endoscopy Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 35: U.S. Endoscopy Devices Market: Import, Export, Tariff and Trade Impact
TABLE 36: U.S. Endoscopy Devices Market: Screening and Public Health Initiatives
TABLE 37: U.S. Endoscopy Devices Market: Sustainability and Environmental Impact
TABLE 38: U.S. Endoscopy Devices Market: Geopolitical and Supply-Risk Analysis
TABLE 39: U.S. Endoscopy Devices Market: Hospital Value Analysis Committee Framework
TABLE 40: U.S. Endoscopy Devices Market: Product Category Snapshot, 2025
TABLE 41: Segment Dashboard; Definition and Scope, by Product Category
TABLE 42: U.S. Endoscopy Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 43: U.S. Endoscopy Devices Market: Product Category Share, 2025 & 2035 (%)
TABLE 44: U.S. Endoscopy Devices Market: Endoscopes Market Size and Forecast, 2021–2035
TABLE 45: U.S. Endoscopy Devices Market: Visualization and Imaging Systems Market Size and Forecast, 2021–2035
TABLE 46: U.S. Endoscopy Devices Market: Endotherapy Devices and Accessories Market Size and Forecast, 2021–2035
TABLE 47: U.S. Endoscopy Devices Market: Insufflation, Fluid-Management and Electrosurgical Systems Market Size and Forecast, 2021–2035
TABLE 48: U.S. Endoscopy Devices Market: Reprocessing, Storage, Service and Infection-Prevention Products Market Size and Forecast, 2021–2035
TABLE 49: U.S. Endoscopy Devices Market: Major Endoscope Subcategory Analysis, 2025 & 2035
TABLE 50: U.S. Endoscopy Devices Market: Application Snapshot, 2025
TABLE 51: Segment Dashboard; Definition and Scope, by Application
TABLE 52: U.S. Endoscopy Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 53: U.S. Endoscopy Devices Market: Application Share, 2025 & 2035 (%)
TABLE 54: U.S. Endoscopy Devices Market: Gastrointestinal Endoscopy Market Size and Forecast, 2021–2035
TABLE 55: U.S. Endoscopy Devices Market: Laparoscopy and General Surgery Market Size and Forecast, 2021–2035
TABLE 56: U.S. Endoscopy Devices Market: Pulmonology and Bronchoscopy Market Size and Forecast, 2021–2035
TABLE 57: U.S. Endoscopy Devices Market: Urology Market Size and Forecast, 2021–2035
TABLE 58: U.S. Endoscopy Devices Market: ENT, Gynecology, Arthroscopy and Other Applications Market Size and Forecast, 2021–2035
TABLE 59: U.S. Endoscopy Devices Market: Gastrointestinal Procedure-Type Analysis, 2025 & 2035
TABLE 60: U.S. Endoscopy Devices Market: End User Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by End User
TABLE 62: U.S. Endoscopy Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 63: U.S. Endoscopy Devices Market: End User Share, 2025 & 2035 (%)
TABLE 64: U.S. Endoscopy Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035
TABLE 65: U.S. Endoscopy Devices Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035
TABLE 66: U.S. Endoscopy Devices Market: Specialty Endoscopy Centers and Physician-Owned Clinics Market Size and Forecast, 2021–2035
TABLE 67: U.S. Endoscopy Devices Market: Academic Medical Centers and Research Institutions Market Size and Forecast, 2021–2035
TABLE 68: U.S. Endoscopy Devices Market: Office-Based Facilities and Other Care Settings Market Size and Forecast, 2021–2035
TABLE 69: U.S. Endoscopy Devices Market: Technology Type Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 71: U.S. Endoscopy Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 72: U.S. Endoscopy Devices Market: Technology Type Share, 2025 & 2035 (%)
TABLE 73: U.S. Endoscopy Devices Market: Reusable Endoscopy Platforms Market Size and Forecast, 2021–2035
TABLE 74: U.S. Endoscopy Devices Market: Single-Use Endoscopy Market Size and Forecast, 2021–2035
TABLE 75: U.S. Endoscopy Devices Market: High-Definition, 4K and 3D Visualization Market Size and Forecast, 2021–2035
TABLE 76: U.S. Endoscopy Devices Market: Artificial Intelligence and Advanced Imaging Market Size and Forecast, 2021–2035
TABLE 77: U.S. Endoscopy Devices Market: Robotic, Navigational and Capsule Endoscopy Market Size and Forecast, 2021–2035
TABLE 78: U.S. Endoscopy Devices Market: Procurement Channel Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 80: U.S. Endoscopy Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 81: U.S. Endoscopy Devices Market: Procurement Channel Share, 2025 & 2035 (%)
TABLE 82: U.S. Endoscopy Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035
TABLE 83: U.S. Endoscopy Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035
TABLE 84: U.S. Endoscopy Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035
TABLE 85: U.S. Endoscopy Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035
TABLE 86: U.S. Endoscopy Devices Market: Ambulatory and Physician-Owned Facility Procurement Market Size and Forecast, 2021–2035
TABLE 87: U.S. Endoscopy Devices Market: Regional Snapshot, 2025
TABLE 88: Segment Dashboard; Definition and Scope, by Geography
TABLE 89: U.S. Endoscopy Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 90: U.S. Endoscopy Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 91: U.S. Endoscopy Devices Market: Regional Procedure Volume and Infrastructure Analysis
TABLE 92: U.S. Endoscopy Devices Market: Regional Reimbursement and Procurement Dynamics
TABLE 93: West Region U.S. Endoscopy Devices Market: Regional Overview and Trends
TABLE 94: West Region U.S. Endoscopy Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 95: West Region U.S. Endoscopy Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Endoscopy Devices Market, by Product Category, 2021–2035
TABLE 97: West Region U.S. Endoscopy Devices Market, by Application, 2021–2035
TABLE 98: West Region U.S. Endoscopy Devices Market, by End User, 2021–2035
TABLE 99: West Region U.S. Endoscopy Devices Market, by Technology Type, 2021–2035
TABLE 100: West Region U.S. Endoscopy Devices Market, by Procurement Channel, 2021–2035
TABLE 101: California Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Washington Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Arizona Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Colorado Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Oregon Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Utah Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Nevada Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: New Mexico Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Idaho Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Montana Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Wyoming Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Alaska Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Hawaii Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Northeast Region U.S. Endoscopy Devices Market: Regional Overview and Trends
TABLE 115: Northeast Region U.S. Endoscopy Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 116: Northeast Region U.S. Endoscopy Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 117: Northeast Region U.S. Endoscopy Devices Market, by Product Category, 2021–2035
TABLE 118: Northeast Region U.S. Endoscopy Devices Market, by Application, 2021–2035
TABLE 119: Northeast Region U.S. Endoscopy Devices Market, by End User, 2021–2035
TABLE 120: Northeast Region U.S. Endoscopy Devices Market, by Technology Type, 2021–2035
TABLE 121: Northeast Region U.S. Endoscopy Devices Market, by Procurement Channel, 2021–2035
TABLE 122: New York Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Massachusetts Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: New Jersey Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Pennsylvania Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Connecticut Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Maine Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: Vermont Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: New Hampshire Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Rhode Island Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Delaware Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: South Region U.S. Endoscopy Devices Market: Regional Overview and Trends
TABLE 133: South Region U.S. Endoscopy Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 134: South Region U.S. Endoscopy Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. Endoscopy Devices Market, by Product Category, 2021–2035
TABLE 136: South Region U.S. Endoscopy Devices Market, by Application, 2021–2035
TABLE 137: South Region U.S. Endoscopy Devices Market, by End User, 2021–2035
TABLE 138: South Region U.S. Endoscopy Devices Market, by Technology Type, 2021–2035
TABLE 139: South Region U.S. Endoscopy Devices Market, by Procurement Channel, 2021–2035
TABLE 140: Texas Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Florida Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Georgia Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: North Carolina Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Tennessee Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: South Carolina Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Alabama Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Mississippi Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Louisiana Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Arkansas Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Kentucky Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Oklahoma Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Virginia Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Maryland Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: West Virginia Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Midwest Region U.S. Endoscopy Devices Market: Regional Overview and Trends
TABLE 156: Midwest Region U.S. Endoscopy Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 157: Midwest Region U.S. Endoscopy Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region U.S. Endoscopy Devices Market, by Product Category, 2021–2035
TABLE 159: Midwest Region U.S. Endoscopy Devices Market, by Application, 2021–2035
TABLE 160: Midwest Region U.S. Endoscopy Devices Market, by End User, 2021–2035
TABLE 161: Midwest Region U.S. Endoscopy Devices Market, by Technology Type, 2021–2035
TABLE 162: Midwest Region U.S. Endoscopy Devices Market, by Procurement Channel, 2021–2035
TABLE 163: Illinois Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Ohio Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Michigan Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Minnesota Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Indiana Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Wisconsin Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: Missouri Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: Iowa Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: Kansas Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 172: Nebraska Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 173: North Dakota Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 174: South Dakota Endoscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 175: U.S. Endoscopy Devices Market: Competitive Landscape Snapshot, 2025
TABLE 176: U.S. Endoscopy Devices Market: Key Company Market Share Analysis, 2025
TABLE 177: U.S. Endoscopy Devices Market: Company Positioning Matrix
TABLE 178: U.S. Endoscopy Devices Market: Product Portfolio Benchmarking
TABLE 179: U.S. Endoscopy Devices Market: Technology and Commercial Capability Benchmarking
TABLE 180: U.S. Endoscopy Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 181: Olympus Corporation: Company Profile
TABLE 182: Boston Scientific Corporation: Company Profile
TABLE 183: Stryker Corporation: Company Profile
TABLE 184: KARL STORZ: Company Profile
TABLE 185: Fujifilm Healthcare Americas Corporation: Company Profile
TABLE 186: PENTAX Medical: Company Profile
TABLE 187: Medtronic: Company Profile
TABLE 188: Johnson & Johnson MedTech and Ethicon: Company Profile
TABLE 189: Ambu A/S: Company Profile
TABLE 190: CONMED Corporation: Company Profile
TABLE 191: Cook Medical: Company Profile
TABLE 192: Intuitive Surgical: Company Profile
TABLE 193: Richard Wolf GmbH: Company Profile
TABLE 194: B. Braun and Aesculap: Company Profile
TABLE 195: Smith+Nephew: Company Profile
TABLE 196: STERIS: Company Profile
TABLE 197: ERBE USA: Company Profile
TABLE 198: Micro-Tech Endoscopy USA: Company Profile
TABLE 199: Merit Medical Systems: Company Profile
TABLE 200: Teleflex Incorporated: Company Profile
TABLE 201: Medline Industries: Company Profile
TABLE 202: Creo Medical: Company Profile
TABLE 203: EndoQuest Robotics: Company Profile
TABLE 204: Noah Medical: Company Profile
TABLE 205: U.S. Endoscopy Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 206: U.S. Endoscopy Devices Market: Forecast Sensitivity Analysis
TABLE 207: U.S. Endoscopy Devices Market: Disruptive Technologies Impact Matrix
TABLE 208: U.S. Endoscopy Devices Market: Emerging Clinical and Business Trends
TABLE 209: U.S. Endoscopy Devices Market: Business Opportunities for Startups and Existing Players
TABLE 210: U.S. Endoscopy Devices Market: Investment Prioritization Matrix
TABLE 211: U.S. Endoscopy Devices Market: White-Space Opportunity Analysis
TABLE 212: U.S. Endoscopy Devices Market: Strategic Recommendations for Manufacturers
TABLE 213: U.S. Endoscopy Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 214: U.S. Endoscopy Devices Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 215: U.S. Endoscopy Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 216: U.S. Endoscopy Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 217: U.S. Endoscopy Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 218: U.S. Endoscopy Devices Market: Go-to-Market Strategy Considerations
TABLE 219: U.S. Endoscopy Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 220: U.S. Endoscopy Devices Market: Partnership, Licensing and Acquisition Strategy
TABLE 221: U.S. Endoscopy Devices Market: Scope and Market Definition Limitations
TABLE 222: U.S. Endoscopy Devices Market: Data Availability and Data Use Limitations
TABLE 223: U.S. Endoscopy Devices Market: Forecasting and Procedure-Volume Estimation Limitations
TABLE 224: U.S. Endoscopy Devices Market: State-Level and Market Share Estimation Limitations
TABLE 225: U.S. Endoscopy Devices Market: Regulatory, Reimbursement and Legal Disclaimer
TABLE 226: U.S. Endoscopy Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Endoscopy Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Estimation and Data Triangulation Framework
FIGURE 4: U.S. Endoscopy Devices Market Ecosystem
FIGURE 5: U.S. Endoscopy Devices Market Stakeholder Map
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: U.S. Endoscopy Devices Market Size, Historical Trend, 2021–2024
FIGURE 8: U.S. Endoscopy Devices Market Size, Forecast and Trend, 2026–2035
FIGURE 9: U.S. Endoscopy Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 10: High-Growth Opportunity Map
FIGURE 11: U.S. Endoscopy Devices Market Dynamics
FIGURE 12: Innovation and Patent Landscape, 2021–2025
FIGURE 13: Clinical Workflow Economics Framework
FIGURE 14: Hospital Capital Procurement Decision Framework
FIGURE 15: Endoscope Reprocessing Workflow
FIGURE 16: Reusable Versus Single-Use Endoscopy Economics
FIGURE 17: PESTEL Analysis
FIGURE 18: Porter’s Five Forces Analysis
FIGURE 19: Endoscopy Device Pricing Trend, 2025–2035
FIGURE 20: Value Chain Analysis
FIGURE 21: Supply Chain Analysis
FIGURE 22: Digitalization and Connected Endoscopy Framework
FIGURE 23: FDA Regulatory Pathway Framework
FIGURE 24: CMS Reimbursement and Site-of-Service Framework
FIGURE 25: Sustainability and Lifecycle Assessment Framework
FIGURE 26: Hospital Value Analysis Committee Decision Matrix
FIGURE 27: Product Category Market Share Analysis, 2025 & 2035
FIGURE 28: Product Category Market Size Forecast, 2021–2035
FIGURE 29: Endoscopes Market Size Forecast and Trend, 2021–2035
FIGURE 30: Visualization and Imaging Systems Market Size Forecast and Trend, 2021–2035
FIGURE 31: Endotherapy Devices and Accessories Market Size Forecast and Trend, 2021–2035
FIGURE 32: Insufflation, Fluid-Management and Electrosurgical Systems Market Size Forecast, 2021–2035
FIGURE 33: Reprocessing, Storage and Infection-Prevention Products Market Size Forecast, 2021–2035
FIGURE 34: Application Market Share Analysis, 2025 & 2035
FIGURE 35: Application Market Size Forecast, 2021–2035
FIGURE 36: Gastrointestinal Endoscopy Market Size Forecast and Trend, 2021–2035
FIGURE 37: Laparoscopy and General Surgery Market Size Forecast and Trend, 2021–2035
FIGURE 38: Pulmonology and Bronchoscopy Market Size Forecast and Trend, 2021–2035
FIGURE 39: Urology Market Size Forecast and Trend, 2021–2035
FIGURE 40: ENT, Gynecology, Arthroscopy and Other Applications Market Size Forecast, 2021–2035
FIGURE 41: End User Market Share Analysis, 2025 & 2035
FIGURE 42: End User Market Size Forecast, 2021–2035
FIGURE 43: Hospitals and Integrated Health Systems Market Size Forecast, 2021–2035
FIGURE 44: Ambulatory Surgery Centers Market Size Forecast, 2021–2035
FIGURE 45: Specialty Endoscopy Centers and Physician-Owned Clinics Market Size Forecast, 2021–2035
FIGURE 46: Academic Medical Centers and Research Institutions Market Size Forecast, 2021–2035
FIGURE 47: Office-Based Facilities and Other Care Settings Market Size Forecast, 2021–2035
FIGURE 48: Technology Type Market Share Analysis, 2025 & 2035
FIGURE 49: Technology Type Market Size Forecast, 2021–2035
FIGURE 50: Reusable Endoscopy Platforms Market Size Forecast, 2021–2035
FIGURE 51: Single-Use Endoscopy Market Size Forecast, 2021–2035
FIGURE 52: High-Definition, 4K and 3D Visualization Market Size Forecast, 2021–2035
FIGURE 53: Artificial Intelligence and Advanced Imaging Market Size Forecast, 2021–2035
FIGURE 54: Robotic, Navigational and Capsule Endoscopy Market Size Forecast, 2021–2035
FIGURE 55: Procurement Channel Market Share Analysis, 2025 & 2035
FIGURE 56: Procurement Channel Market Size Forecast, 2021–2035
FIGURE 57: Direct Hospital and Health System Procurement Market Size Forecast, 2021–2035
FIGURE 58: Integrated Delivery Network Enterprise Contracts Market Size Forecast, 2021–2035
FIGURE 59: Group Purchasing Organization Contracts Market Size Forecast, 2021–2035
FIGURE 60: Distributor and Specialty Supplier Sales Market Size Forecast, 2021–2035
FIGURE 61: Ambulatory and Physician-Owned Facility Procurement Market Size Forecast, 2021–2035
FIGURE 62: Regional Market Share Analysis, 2025 & 2035
FIGURE 63: Regional Market Size Forecast and Trend, 2021–2035
FIGURE 64: Regional Procedure Volume and Endoscopy Infrastructure Map
FIGURE 65: West Region U.S. Endoscopy Devices Market Share and Leading Players, 2025
FIGURE 66: West Region Market Share Analysis by State, 2025
FIGURE 67: West Region Market Size Forecast and Trend, 2021–2035
FIGURE 68: California Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 69: Washington Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 70: Arizona Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 71: Colorado Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 72: Oregon Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 73: Utah Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 74: Nevada Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 75: New Mexico Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 76: Idaho Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 77: Montana Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 78: Wyoming Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 79: Alaska Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 80: Hawaii Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 81: Northeast Region U.S. Endoscopy Devices Market Share and Leading Players, 2025
FIGURE 82: Northeast Region Market Share Analysis by State, 2025
FIGURE 83: Northeast Region Market Size Forecast and Trend, 2021–2035
FIGURE 84: New York Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 85: Massachusetts Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 86: New Jersey Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 87: Pennsylvania Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 88: Connecticut Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 89: Maine Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 90: Vermont Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 91: New Hampshire Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 92: Rhode Island Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 93: Delaware Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 94: South Region U.S. Endoscopy Devices Market Share and Leading Players, 2025
FIGURE 95: South Region Market Share Analysis by State, 2025
FIGURE 96: South Region Market Size Forecast and Trend, 2021–2035
FIGURE 97: Texas Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 98: Florida Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 99: Georgia Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 100: North Carolina Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 101: Tennessee Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 102: South Carolina Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 103: Alabama Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 104: Mississippi Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 105: Louisiana Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 106: Arkansas Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 107: Kentucky Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 108: Oklahoma Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 109: Virginia Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 110: Maryland Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 111: West Virginia Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 112: Midwest Region U.S. Endoscopy Devices Market Share and Leading Players, 2025
FIGURE 113: Midwest Region Market Share Analysis by State, 2025
FIGURE 114: Midwest Region Market Size Forecast and Trend, 2021–2035
FIGURE 115: Illinois Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 116: Ohio Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 117: Michigan Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 118: Minnesota Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 119: Indiana Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 120: Wisconsin Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 121: Missouri Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 122: Iowa Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 123: Kansas Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 124: Nebraska Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 125: North Dakota Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 126: South Dakota Endoscopy Devices Market Size Forecast, 2021–2035
FIGURE 127: Competitive Landscape and Key Company Market Share, 2025
FIGURE 128: Company Positioning Matrix
FIGURE 129: Key Player Product Portfolio Benchmarking
FIGURE 130: Technology and Commercial Capability Benchmarking
FIGURE 131: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 132: U.S. Endoscopy Devices Innovation Roadmap
FIGURE 133: Artificial Intelligence-Assisted Endoscopy Adoption Roadmap
FIGURE 134: Single-Use Endoscopy Adoption and Opportunity Map
FIGURE 135: Therapeutic Endoscopy Innovation Roadmap
FIGURE 136: Robotic and Navigational Bronchoscopy Opportunity Map
FIGURE 137: Endoscope Reprocessing Technology Roadmap
FIGURE 138: Future Market Scenario Analysis, 2026–2035
FIGURE 139: Forecast Sensitivity Analysis
FIGURE 140: Disruptive Technologies Impact Matrix
FIGURE 141: Emerging Clinical and Business Trends Matrix
FIGURE 142: Investment Prioritization Matrix
FIGURE 143: White-Space Opportunity Map
FIGURE 144: Strategic Growth Roadmap for U.S. Endoscopy Device Companies
FIGURE 145: Hospital and ASC Procurement Strategy Framework
FIGURE 146: Go-to-Market Strategy Framework
FIGURE 147: Product Positioning and Portfolio Expansion Framework
FIGURE 148: Partnership, Licensing and Acquisition Framework
FIGURE 149: Report Scope and Disclaimer Framework